Page last updated: 2024-10-30

mebendazole and Leukemia, Lymphoblastic, Acute, T Cell

mebendazole has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 2 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Research Excerpts

ExcerptRelevanceReference
"Mebendazole (MBZ) is a tubulin-suppressive antihelmintic agent with low toxicity, which has been repurposed to treat different types of tumors."1.56Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells. ( Lou, K; Ma, H; Song, X; Wang, W; Wang, X; Xu, H; Zhou, X, 2020)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Smith, C1
Touzart, A1
Simonin, M1
Tran-Quang, C1
Hypolite, G1
Latiri, M1
Andrieu, GP1
Balducci, E1
Dourthe, MÉ1
Goyal, A1
Huguet, F1
Petit, A1
Ifrah, N1
Baruchel, A1
Dombret, H1
Macintyre, E1
Plass, C1
Ghysdael, J1
Boissel, N1
Asnafi, V1
Wang, X1
Lou, K1
Song, X1
Ma, H1
Zhou, X1
Xu, H1
Wang, W1

Other Studies

2 other studies available for mebendazole and Leukemia, Lymphoblastic, Acute, T Cell

ArticleYear
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALL.
    Molecular cancer, 2023, 01-18, Volume: 22, Issue:1

    Topics: Basic Helix-Loop-Helix Transcription Factors; Humans; Mebendazole; Precursor T-Cell Lymphoblastic Le

2023
Mebendazole is a potent inhibitor to chemoresistant T cell acute lymphoblastic leukemia cells.
    Toxicology and applied pharmacology, 2020, 06-01, Volume: 396

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Caspase 3; Caspase 7; Cell Cycle; Cell Line, Tumo

2020